Koninklijke KPN Earnings Call Transcripts
Fiscal Year 2026
-
Service revenues and EBITDA grew year-on-year, with strong SME and consumer performance offsetting declines in Tailored Solutions. Free cash flow dipped due to timing effects but is expected to recover, and full-year guidance is reiterated.
-
The meeting reviewed strong financial results, strategic progress in fiber rollout and digital transformation, and robust ESG integration. All proposals, including dividend and board appointments, were approved by large majorities, with shareholders engaging on sustainability, cost control, and governance.
Fiscal Year 2025
-
Service revenues grew 2.7% year-on-year, with all segments contributing and EBITDA, free cash flow, and margins exceeding guidance. 2026 outlook targets 2%-2.5% service revenue growth, EUR 2.67 billion EBITDA, and over EUR 950 million free cash flow, with continued shareholder returns and cost savings initiatives.
-
Midway through its transformation, the company leads in fiber and 5G, with strong financials and a disciplined capital allocation plan. Fiber rollout will slow, focusing on activation and efficiency, while free cash flow and dividends are set to rise, supported by ongoing cost savings and digital transformation.
-
Service revenues and EBITDA grew across all segments, with strong fiber expansion and robust free cash flow. The company maintains a solid balance sheet, reiterates its 2025 and midterm targets, and expects continued growth despite a competitive market and regulatory reviews.
-
Group service revenues rose 3.7% year-on-year, with strong B2B and wholesale growth, and adjusted EBITDA up 6.4% aided by IPR settlements. Free cash flow declined due to timing effects but is expected to recover in H2, and full-year guidance for EBITDA and cash flow was raised.
-
Group service revenues rose 3.8% year-over-year, with strong B2B and wholesale growth, and adjusted EBITDA after leases up 4.7%. Free cash flow declined due to timing of tax and interest payments but is expected to recover in H2. 2025 guidance for EBITDA and free cash flow was upgraded following the Althio acquisition.
-
The meeting reviewed strong financial results, confirmed continued investment in fiber and 5G, and adopted all proposals, including dividend increases and board reappointments. Strategic focus remains on digitization, sustainability, and market leadership, with robust governance and risk management in place.
Fiscal Year 2024
-
Delivered strong 2024 results with over 3% service revenue growth, robust fiber expansion, and improved free cash flow. 2025 guidance targets continued 3% growth in service revenues and EBITDA, stable CapEx, and higher shareholder returns, with a major CapEx step-down expected from 2027.
-
Group service revenues grew 3.4% organically in Q3, with all segments contributing and strong fiber rollout progress. EBITDA margin remained above 45%, and free cash flow was stable despite higher CapEx and taxes. Full-year and midterm growth targets are reaffirmed.
-
The meeting focused on appointing Mr. Rob Shuter to the Supervisory Board, with strong support from both the board and Central Works Council. The proposal was adopted with a significant majority of votes represented by proxy.
-
European telco sector dynamics are improving, with KPN leveraging a stable regulatory environment, strong fiber rollout, and ESG leadership to drive growth. Financial targets include 3% annual revenue and EBITDA growth, a 15% ROCE by 2027, and €3.8 billion in shareholder returns.
-
Q2 saw strong revenue and EBITDA growth, driven by Consumer and Business segments, with the Youfone acquisition and fiber expansion boosting customer bases. Wholesale faced increased competition, but overall guidance for 2024 and midterm ambitions remain on track.
-
A new strategic partnership will create a major Dutch tower company, consolidating assets from KPN, NOVEC, and OTC under a 51/49 structure with APG. The deal streamlines contracts, boosts operational control, and is expected to deliver strong EBITDA and cash flow growth, pending regulatory approval in Q4 2024.